Encompass Health (NYSE:EHC) Price Target Increased to $108.00 by Analysts at Barclays

Encompass Health (NYSE:EHC) had its target price boosted by research analysts at Barclays from $101.00 to $108.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 31.37% from the company’s current price.

Several other brokerages have also issued reports on EHC. Royal Bank of Canada reiterated an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Mizuho lifted their target price on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Truist Financial lifted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Finally, Stephens reiterated an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $85.44.

Encompass Health Stock Performance

Shares of Encompass Health stock traded down $0.59 during trading on Thursday, hitting $82.21. 637,626 shares of the company’s stock were exchanged, compared to its average volume of 660,989. The stock has a market capitalization of $8.23 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 1.53 and a beta of 0.94. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.28 and a current ratio of 1.28. The business has a 50-day simple moving average of $77.89 and a 200-day simple moving average of $70.67. Encompass Health has a 52-week low of $57.55 and a 52-week high of $85.84.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $0.93 by $0.19. The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The firm’s revenue was up 13.4% on a year-over-year basis. During the same quarter last year, the business earned $0.88 earnings per share. On average, research analysts forecast that Encompass Health will post 3.96 EPS for the current year.

Hedge Funds Weigh In On Encompass Health

A number of institutional investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Encompass Health by 75.7% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 720,173 shares of the company’s stock worth $59,472,000 after purchasing an additional 310,285 shares during the period. Rice Hall James & Associates LLC raised its stake in Encompass Health by 15.1% during the first quarter. Rice Hall James & Associates LLC now owns 55,111 shares of the company’s stock worth $4,551,000 after purchasing an additional 7,225 shares during the period. Louisiana State Employees Retirement System raised its stake in Encompass Health by 2.5% during the first quarter. Louisiana State Employees Retirement System now owns 28,900 shares of the company’s stock worth $2,387,000 after purchasing an additional 700 shares during the period. Stonegate Investment Group LLC purchased a new stake in shares of Encompass Health in the 1st quarter valued at approximately $229,000. Finally, Legacy Wealth Asset Management LLC raised its stake in shares of Encompass Health by 1.5% in the 1st quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock valued at $712,000 after acquiring an additional 130 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.